Members |
targetComponentId |
Beclomethasone dipropionate 8.4mg |
Product containing only beclometasone in pulmonary dose form (medicinal product form) |
Beclomethasone dipropionate 80mcg aerosol |
Product containing only beclometasone in pulmonary dose form (medicinal product form) |
Beclomethasone dipropionate 84mcg inhalation aerosol |
Product containing only beclometasone in pulmonary dose form (medicinal product form) |
Beclomethasone dipropionate+salbutamol |
Product containing beclometasone and salbutamol (medicinal product) |
Beclomethasone dipropionate+salbutamol 200micrograms/400micrograms inhalation capsule |
Product containing only beclometasone and salbutamol (medicinal product) |
Bedpan |
Bedpan |
Beetle |
Order Coleoptera (organism) |
Behavior disorder of childhood and adolescence |
Behavior problem of childhood and adolescence (finding) |
Bell-Buettner operation for subtotal abdominal hysterectomy |
Subtotal abdominal hysterectomy |
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg prolonged-release oral tablet |
Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
Bemiparin sodium 22500iu/mL injection solution 0.3mL prefilled syringe |
Product containing precisely bemiparin sodium 22500 unit/1 milliliter conventional release solution for injection (clinical drug) |
Bemiparin sodium 40000iu/mL injection solution 0.4mL prefilled syringe |
Bemiparin sodium 40000 unit/mL solution for injection |
Bendamustine 100mg powder for injection solution 20ml vial |
Bendamustine hydrochloride 100 mg powder for solution for injection vial |
Benefits - other, specified |
Benefits and pensions |
Benefits - other, specified |
Benefits and pensions |
Benign adenomatous neoplasm - category |
Benign adenomatous neoplasm (morphologic abnormality) |
Benign carcinoid neoplasm of bronchus |
Carcinoid tumour of bronchus |
Benign carcinoid of large intestine |
Well-differentiated neuroendocrine tumor of large intestine |
Benign carcinoid of lung |
Carcinoid tumour of lung |
Benign carcinoid tumor |
Well-differentiated neuroendocrine tumour |
Benign carcinoid tumor |
Well-differentiated neuroendocrine tumor (morphologic abnormality) |
Benign carcinoid tumor of gastrointestinal tract |
Well-differentiated neuroendocrine tumor of gastrointestinal tract |
Benign carcinoid tumor of left kidney |
Well-differentiated neuroendocrine tumor of left kidney (disorder) |
Benign carcinoid tumor of liver |
Well-differentiated neuroendocrine tumor of liver |
Benign carcinoid tumor of pancreas |
Neuroendocrine tumor of pancreas (disorder) |
Benign carcinoid tumor of right kidney |
Well-differentiated neuroendocrine tumor of right kidney (disorder) |
Benign childhood epilepsy with centrotemporal spikes, non-refractory |
A common type of self-limited focal epilepsy syndrome, which begins typically between four and ten years (peak is seven years; range three to twelve years). Seizures are focal, infrequent (most children have fewer than ten in lifetime), brief (typically less than two to three minutes) and occur mostly in sleep (eighty to ninety percent of children). Individuals may have frequent seizures over a few days or weeks and then several months before subsequent seizure. Focal seizures with characteristic frontoparietal opercular features and/or nocturnal bilateral tonic-clonic seizures are mandatory for diagnosis. Characteristic semiology includes somatosensory symptoms (unilateral numbness or paresthesia of the tongue, lips, gums and inner cheek), orofacial motor signs (unilateral tonic or clonic contractions), speech arrest (dysarthria or anarthria) with preserved understanding, and sialorrhea. Seizures may evolve rapidly to tonic-clonic activity of the ipsilateral upper limb, to an ipsilateral hemiclonic seizure, or to a focal to bilateral tonic-clonic seizure. Todd paresis may occur postictally. Seizures occurring during sleep are seen within one hour of falling asleep or one to two hours prior to awakening. Development and cognition are typically normal. Neurological examination is normal. The electroencephalogram (EEG) background activity is normal. EEG must show centrotemporal biphasic epileptiform discharges which are characteristically high-amplitude complexes (less than 200 microvolts, peak to trough) that activate in drowsiness and sleep. MRI is normal or has nonspecific findings. |
Benign cyst of breast |
Cyst of breast (disorder) |
Benign epithelial neoplasm - category |
Benign epithelial neoplasm |
Benign essential hypertension complicating AND/OR reason for care during puerperium |
Benign essential hypertension complicating pregnancy, childbirth and the puerperium |
Benign essential hypertension complicating pregnancy, childbirth and the puerperium with postnatal complication |
Benign essential hypertension complicating pregnancy, childbirth and the puerperium |
Benign familial hematuria |
Thin basement membrane disease |
Benign fibrohistiocytic neoplasm - category |
Benign fibrohistiocytic neoplasm |
Benign fibromatous neoplasm - category |
Benign fibromatous neoplasm |
Benign frontal epilepsy of childhood |
A type of focal epilepsy where all the seizures originate within the frontal lobe. |
Benign insulinoma |
Malignant insulinoma |
Benign leiomyomatous neoplasm - category |
Leiomyoma |
Benign mammary dysplasia NOS |
Benign mammary dysplasia |
Benign mammary dysplasia NOS |
Benign mammary dysplasia |
Benign metastasizing leiomyoma of uterus |
Metastasizing leiomyoma of uterus (disorder) |
Benign neonatal seizures |
A type of self-limited focal epilepsy with onset typically between day two and seven of life. Seizures are focal tonic at onset, affecting the head, face, and limbs. Focal clonic or tonic seizures may evolve to bilateral tonic or clonic seizures. Onset may alternate between hemispheres. Autonomic features (apnea and cyanosis) are present in one third of seizures and may be the predominant manifestation. Seizure semiology may progress in a sequential pattern with tonic, clonic, myoclonic and autonomic features following each other without a single predominant feature. Clusters of seizures may occur over hours or days with the neonate behaving normally between events. Developmental progress is usually normal. The electroencephalogram (EEG) background is normal or has minor nonspecific abnormalities. Focal interictal epileptiform abnormalities can be seen in the central, centrotemporal or frontotemporal regions. MRI is normal or has nonspecific findings. Pathogenic variants are seen in KCNQ2, KCNQ3 and SCN2A. |
Benign neoplasm NOS |
Benign neoplastic disease (disorder) |
Benign neoplasm NOS |
Benign neoplastic disease (disorder) |
Benign neoplasm of areola of female breast |
Benign neoplasm of areola |
Benign neoplasm of areola of male breast |
Benign neoplasm of areola |
Benign neoplasm of axillary tail of female breast |
Benign neoplasm of axillary tail of breast (disorder) |
Benign neoplasm of central portion of female breast |
Benign neoplasm of central portion of breast |
Benign neoplasm of connective and soft tissue of peritoneum |
Benign neoplasm of the peritoneum |
Benign neoplasm of ectopic female breast tissue |
Benign neoplasm of ectopic site of breast (disorder) |
Benign neoplasm of ectopic male breast tissue |
Benign neoplasm of ectopic site of breast (disorder) |
Benign neoplasm of female breast |
Benign neoplasm of breast |
Benign neoplasm of female breast |
Benign neoplasm of breast |
Benign neoplasm of ill-defined site |
Benign neoplastic disease (disorder) |
Benign neoplasm of left female breast |
Benign neoplasm of left breast (disorder) |
Benign neoplasm of lower inner quadrant of female breast |
Benign neoplasm of lower inner quadrant of breast (disorder) |
Benign neoplasm of lower outer quadrant of female breast |
Benign neoplasm of lower outer quadrant of breast (disorder) |
Benign neoplasm of male breast |
Benign neoplasm of breast |
Benign neoplasm of male breast |
Benign neoplasm of breast |
Benign neoplasm of nipple of female breast |
Benign neoplasm of nipple (disorder) |
Benign neoplasm of nipple of male breast |
Benign neoplasm of nipple (disorder) |
Benign neoplasm of oral cavity NOS |
Benign neoplasm of oral cavity (disorder) |
Benign neoplasm of oral cavity NOS |
Benign neoplasm of oral cavity (disorder) |
Benign neoplasm of other specified sites of uterus |
Benign neoplasm of uterus |
Benign neoplasm of right female breast |
Benign neoplasm of right breast (disorder) |
Benign neoplasm of skin (& various types) |
Benign neoplasm of skin |
Benign neoplasm of upper inner quadrant of female breast |
Benign neoplasm of upper inner quadrant of breast |
Benign neoplasm of upper outer quadrant of female breast |
Benign neoplasm of upper outer quadrant of breast (disorder) |
Benign neoplastic process |
Neoplasm, benign |
Benign nerve sheath tumor - category |
Benign nerve sheath tumor |
Benign neuroendocrine neoplasm - category |
Benign neuroendocrine neoplasm |
Benign neuroendocrine neoplasm of ascending colon |
Neuroendocrine neoplasm of ascending colon |
Benign neuroendocrine neoplasm of ileum |
Neuroendocrine neoplasm of ileum (disorder) |
Benign neuroendocrine neoplasm of jejunum |
Neuroendocrine neoplasm of jejunum (disorder) |
Benign neuroendocrine neoplasm of large intestine |
Neuroendocrine neoplasm of large intestine (disorder) |
Benign neuroendocrine neoplasm of pancreas |
Neuroendocrine neoplasm of pancreas (disorder) |
Benign neuroendocrine neoplasm of sigmoid colon |
Neuroendocrine neoplasm of sigmoid colon |
Benign neuroendocrine neoplasm of transverse colon |
Neuroendocrine neoplasm of transverse colon (disorder) |
Benign paroxysmal positional vertigo nystagmus |
Nystagmus due to benign paroxysmal positional vertigo |
Benign postural proteinuria |
Orthostatic proteinuria |
Benign psychomotor epilepsy of childhood |
A group of epilepsies characterized by age-dependent occurrence of drug responsive focal seizures in otherwise normal children. Seizures are focal motor or sensory with or without impaired awareness and may evolve to bilateral tonic-clonic seizures. Remission usually occurs by puberty. Development and cognition are typically normal. Neurological examination is normal. No significant structural lesions of the brain are present, and presumed genetic factors have an important role. The electroencephalogram (EEG) background activity is normal. Seizure semiology and EEG features are specific for each of the syndromes included in this group. |
Bennett respirator therapy |
Respiratory therapy |
Benoxinate hydrochloride 0.2% eye drops |
Oxybuprocaine only product |
Benoxinate hydrochloride 0.4% eye drops |
Oxybuprocaine only product |
Benoxinate hydrochloride+fluorescein sodium 0.3%/0.125% eye drops |
Product containing only fluorescein stain and oxybuprocaine in ocular dose form (medicinal product form) |
Benoxinate hydrochloride+fluorescein sodium 0.4%/0.25% ophthalmic solution |
Product containing only fluorescein stain and oxybuprocaine in ocular dose form (medicinal product form) |
Benton visual behavior test |
Benton visual retention test (assessment scale) |
Benzalkonium chloride (in water) |
Benzalkonium chloride |
Benzathine penicillin allergy |
Allergy to benzylpenicillin |
Benzhexol 2mg/5mL conventional release oral solution |
Product containing only trihexyphenidyl in oral dose form (medicinal product form) |
Benzhexol 2mg/5mL s/f oral solution |
Product containing only trihexyphenidyl in oral dose form (medicinal product form) |
Benzisoxazole derivative antipsychotic agent |
Benzisoxazole derivative |
Benzoate 1,2-dioxygenase |
Benzoate 1,2-dioxygenase |
Benzocaine + trimethobenzamide hydrochlor 2%ww/100mg suppositories |
Benzocaine and trimethobenzamide only product in rectal dose form |
Benzocaine + trimethobenzamide hydrochloride 2%ww/100mg rectal suppositories |
Benzocaine and trimethobenzamide only product in rectal dose form |
Benzocaine 20% otic drops |
Product containing precisely benzocaine 200 milligram/1 milliliter conventional release ear solution (clinical drug) |
Benzodiazepine sedative allergy |
Allergy to benzodiazepine |
Benzoic acid allergy |
Non-allergic hypersensitivity to benzoic acid |
Benzoyl peroxide |
Benzoyl peroxide |
Benzoyl peroxide + clindamycin phosphate |
Product containing benzoyl peroxide and clindamycin (medicinal product) |
Benzoyl peroxide + sulfur 10%ww/5%ww |
Product containing benzoyl peroxide and sulfur (medicinal product) |